AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lim, V.
Right arrow Articles by Zyroff, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lim, V.
Right arrow Articles by Zyroff, J.

American Journal of Neuroradiology, Vol 11, Issue 5 975-982, Copyright © 1990 by American Society of Neuroradiology


ARTICLES

Spinal cord pial metastases: MR imaging with gadopentetate dimeglumine

V Lim, DF Sobel and J Zyroff
Department of Radiology, Scripps Clinic and Research Foundation, La Jolla, CA 92037.

The purpose of this investigation was to describe gadopentetate- dimeglumine-enhanced MR findings in metastatic disease to the pial lining of the spinal cord. Correlation was made with clinical data, other radiologic studies, and pathologic findings. Eighty-six patients with a known malignancy and unexplained neurologic signs or symptoms were studied with pre- and postcontrast T1-weighted images. In seven of these patients, abnormal enhancement of the pial lining of the cord was seen on the sagittal postcontrast T1-weighted images. This appeared as a thin rim of enhancement along the surface of the cord in six patients and as a focal, thick rim of enhancement in addition to the thin rim of enhancement in the seventh patient. Axial images confirmed the location along the pial lining in each case. Precontrast T1-weighted images in all seven cases and precontrast T2-weighted images in five cases failed to detect any focal abnormalities of the pial lining of the cord. Pathologic confirmation was available in five of the seven patients. Primary malignancies in these patients included breast carcinoma (two), lymphoma (one), leukemia (one), adenocarcinoma of the lung (one), prostate carcinoma (one), and malignant melanoma (one). Three of seven patients had metastatic disease evident only within the CNS, while four patients had widespread disease outside the CNS. We conclude that contrast-enhanced MR imaging is useful in the diagnosis of pial spread of metastatic disease in patients with a known primary malignancy and unexplained neurologic signs or symptoms.


This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
A.J. Johnson, J. Ying, T. El Gammal, R.D. Timmerman, R.Y. Kim, and B. Littenberg
Which MR Imaging Sequences Are Necessary in Determining the Need for Radiation Therapy for Cord Compression? A Prospective Study
AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 32 - 37.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
K. K. Koeller, R. S. Rosenblum, and A. L. Morrison
Neoplasms of the Spinal Cord and Filum Terminale: Radiologic-Pathologic Correlation
RadioGraphics, November 1, 2000; 20(6): 1721 - 1749.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
M. C. Chamberlain
Topical Review: A Review of Leptomeningeal Metastases in Pediatrics
J Child Neurol, May 1, 1995; 10(3): 191 - 199.
[Abstract] [PDF]


Home page
NEJMHome page
R. R Edelman and S. Warach
Magnetic Resonance Imaging- First of Two Parts
N. Engl. J. Med., March 11, 1993; 328(10): 708 - 716.
[Full Text]